Literature DB >> 19501586

Ras activity levels control the development of pancreatic diseases.

Baoan Ji1, Lilian Tsou, Huamin Wang, Sebastian Gaiser, David Z Chang, Jaroslaw Daniluk, Yan Bi, Tobias Grote, Daniel S Longnecker, Craig D Logsdon.   

Abstract

BACKGROUND & AIMS: Differentiated pancreatic acinar cells expressing endogenous levels of mutant K-Ras do not spontaneously develop pancreatic ductal adenocarcinoma (PDAC). However, we hypothesized that acinar cells would develop PDAC in the presence of Ras activity levels mimicking those of human tumor cells.
METHODS: We measured Ras activity in PDAC cells from mice and humans using a Raf pull-down assay. We compared the effects of acinar cell expression of mutant K-Ras at endogenous and elevated levels on Ras activity and on the development of PDAC.
RESULTS: Ras activity was greatly elevated in PDAC cells compared with nontransformed cells expressing endogenous levels of mutant K-Ras. Expression of endogenous levels of mutant K-Ras in differentiated acinar cells resulted in moderately elevated Ras activity and in sparse murine pancreatic intraepithelial neoplasias (mPanINs) that did not spontaneously advance to PDAC unless the tumor suppressor p53 was simultaneously deleted. In contrast, expression of mutant K-Ras at higher levels generated Ras activity equal to that in PDAC. High Ras activity mimicking levels in PDAC led to acinar cell senescence and generated inflammation and fibrosis resembling the histologic features of chronic pancreatitis. With higher Ras activity in acinar cells, abundant mPanINs formed and spontaneously progressed to both cystic papillary carcinoma and metastatic PDAC.
CONCLUSIONS: There is an important relationship between Ras activity levels and the progression of PDAC. Sufficient Ras activity in pancreatic acinar induces several important pancreatic disease manifestations not previously reported and supports a potential direct linkage between chronic pancreatitis, cystic papillary carcinoma, and PDAC.

Entities:  

Mesh:

Year:  2009        PMID: 19501586      PMCID: PMC2789008          DOI: 10.1053/j.gastro.2009.05.052

Source DB:  PubMed          Journal:  Gastroenterology        ISSN: 0016-5085            Impact factor:   22.682


  35 in total

1.  Efficient selection for high-expression transfectants with a novel eukaryotic vector.

Authors:  H Niwa; K Yamamura; J Miyazaki
Journal:  Gene       Date:  1991-12-15       Impact factor: 3.688

2.  Frequency of K-ras mutations in pancreatic intraductal neoplasias associated with pancreatic ductal adenocarcinoma and chronic pancreatitis: a meta-analysis.

Authors:  Matthias Löhr; Günter Klöppel; Patrick Maisonneuve; Albert B Lowenfels; Jutta Lüttges
Journal:  Neoplasia       Date:  2005-01       Impact factor: 5.715

3.  Trp53R172H and KrasG12D cooperate to promote chromosomal instability and widely metastatic pancreatic ductal adenocarcinoma in mice.

Authors:  Sunil R Hingorani; Lifu Wang; Asha S Multani; Chelsea Combs; Therese B Deramaudt; Ralph H Hruban; Anil K Rustgi; Sandy Chang; David A Tuveson
Journal:  Cancer Cell       Date:  2005-05       Impact factor: 31.743

4.  Pancreatic intraepithelial neoplasia: a new nomenclature and classification system for pancreatic duct lesions.

Authors:  R H Hruban; N V Adsay; J Albores-Saavedra; C Compton; E S Garrett; S N Goodman; S E Kern; D S Klimstra; G Klöppel; D S Longnecker; J Lüttges; G J Offerhaus
Journal:  Am J Surg Pathol       Date:  2001-05       Impact factor: 6.394

5.  Ductal lesions in patients with chronic pancreatitis show K-ras mutations in a frequency similar to that in the normal pancreas and lack nuclear immunoreactivity for p53.

Authors:  J Lüttges; A Diederichs; M A Menke; I Vogel; B Kremer; G Klöppel
Journal:  Cancer       Date:  2000-06-01       Impact factor: 6.860

6.  Activation of MAP kinase kinase (MEK) and Ras by cholecystokinin in rat pancreatic acini.

Authors:  R D Duan; C F Zheng; K L Guan; J A Williams
Journal:  Am J Physiol       Date:  1995-06

Review 7.  K-ras oncogene activation in adenocarcinoma of the human pancreas. A study of 82 carcinomas using a combination of mutant-enriched polymerase chain reaction analysis and allele-specific oligonucleotide hybridization.

Authors:  R H Hruban; A D van Mansfeld; G J Offerhaus; D H van Weering; D C Allison; S N Goodman; T W Kensler; K K Bose; J L Cameron; J L Bos
Journal:  Am J Pathol       Date:  1993-08       Impact factor: 4.307

8.  Analysis of K-ras gene mutation in hyperplastic duct cells of the pancreas without pancreatic disease.

Authors:  M Tada; M Ohashi; Y Shiratori; T Okudaira; Y Komatsu; T Kawabe; H Yoshida; R Machinami; K Kishi; M Omata
Journal:  Gastroenterology       Date:  1996-01       Impact factor: 22.682

9.  Periacinar stellate shaped cells in rat pancreas: identification, isolation, and culture.

Authors:  M V Apte; P S Haber; T L Applegate; I D Norton; G W McCaughan; M A Korsten; R C Pirola; J S Wilson
Journal:  Gut       Date:  1998-07       Impact factor: 23.059

10.  Most human carcinomas of the exocrine pancreas contain mutant c-K-ras genes.

Authors:  C Almoguera; D Shibata; K Forrester; J Martin; N Arnheim; M Perucho
Journal:  Cell       Date:  1988-05-20       Impact factor: 41.582

View more
  107 in total

1.  An NF-κB pathway-mediated positive feedback loop amplifies Ras activity to pathological levels in mice.

Authors:  Jaroslaw Daniluk; Yan Liu; Defeng Deng; Jun Chu; Haojie Huang; Sebastian Gaiser; Zobeida Cruz-Monserrate; Huamin Wang; Baoan Ji; Craig D Logsdon
Journal:  J Clin Invest       Date:  2012-03-12       Impact factor: 14.808

2.  Mast cells in tumor microenvironment promotes the in vivo growth of pancreatic ductal adenocarcinoma.

Authors:  David Z Chang; Ying Ma; Baoan Ji; Huamin Wang; Defeng Deng; Yan Liu; James L Abbruzzese; Yong-jun Liu; Craig D Logsdon; Patrick Hwu
Journal:  Clin Cancer Res       Date:  2011-10-05       Impact factor: 12.531

Review 3.  Molecular biology of pancreatic ductal adenocarcinoma progression: aberrant activation of developmental pathways.

Authors:  Andrew D Rhim; Ben Z Stanger
Journal:  Prog Mol Biol Transl Sci       Date:  2010       Impact factor: 3.622

4.  Oncogenic KRas suppresses inflammation-associated senescence of pancreatic ductal cells.

Authors:  Kyoung Eun Lee; Dafna Bar-Sagi
Journal:  Cancer Cell       Date:  2010-11-16       Impact factor: 31.743

5.  Role of the ductal transcription factors HNF6 and Sox9 in pancreatic acinar-to-ductal metaplasia.

Authors:  Pierre-Paul Prévot; Alexandru Simion; Adrien Grimont; Marta Colletti; Abed Khalaileh; Géraldine Van den Steen; Christine Sempoux; Xiaobo Xu; Véronique Roelants; Jacob Hald; Luc Bertrand; Harry Heimberg; Stephen F Konieczny; Yuval Dor; Frédéric P Lemaigre; Patrick Jacquemin
Journal:  Gut       Date:  2012-01-22       Impact factor: 23.059

Review 6.  Differentiation and Inflammation: 'Best Enemies' in Gastrointestinal Carcinogenesis.

Authors:  Nathan M Krah; L Charles Murtaugh
Journal:  Trends Cancer       Date:  2016-12

7.  Detection of pancreatic cancer tumours and precursor lesions by cathepsin E activity in mouse models.

Authors:  Zobeida Cruz-Monserrate; Wael R Abd-Elgaliel; Tobias Grote; Defeng Deng; Baoan Ji; Thiruvengadam Arumugam; Huamin Wang; Ching-Hsuan Tung; Craig D Logsdon
Journal:  Gut       Date:  2011-11-07       Impact factor: 23.059

Review 8.  Cells of origin of pancreatic neoplasms.

Authors:  Junpei Yamaguchi; Yukihiro Yokoyama; Toshio Kokuryo; Tomoki Ebata; Masato Nagino
Journal:  Surg Today       Date:  2017-03-04       Impact factor: 2.549

9.  Mouse tissues that undergo neoplastic progression after K-Ras activation are distinguished by nuclear translocation of phospho-Erk1/2 and robust tumor suppressor responses.

Authors:  Neha Parikh; Ryan L Shuck; Thuy-Ai Nguyen; Alan Herron; Lawrence A Donehower
Journal:  Mol Cancer Res       Date:  2012-04-24       Impact factor: 5.852

Review 10.  Deploying mouse models of pancreatic cancer for chemoprevention studies.

Authors:  Paul J Grippo; David A Tuveson
Journal:  Cancer Prev Res (Phila)       Date:  2010-11-02
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.